Loading…
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current assays identifying tumor-specific functional activation measure the upregulation of surface molecules,...
Saved in:
Published in: | Frontiers in immunology 2021-10, Vol.12, p.705422-705422 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c534t-34b68edd5cc2d433833d1aa1097815ed6a989421155fe3cccde559aa239ddf523 |
---|---|
cites | cdi_FETCH-LOGICAL-c534t-34b68edd5cc2d433833d1aa1097815ed6a989421155fe3cccde559aa239ddf523 |
container_end_page | 705422 |
container_issue | |
container_start_page | 705422 |
container_title | Frontiers in immunology |
container_volume | 12 |
creator | Draghi, Arianna Chamberlain, Christopher Aled Khan, Shawez Papp, Krisztian Lauss, Martin Soraggi, Samuele Radic, Haja Dominike Presti, Mario Harbst, Katja Gokuldass, Aishwarya Kverneland, Anders Nielsen, Morten Westergaard, Marie Christine Wulff Andersen, Mads Hald Csabai, Istvan Jönsson, Göran Szallasi, Zoltan Svane, Inge Marie Donia, Marco |
description | Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current
assays identifying tumor-specific functional activation measure the upregulation of surface molecules,
production of antitumor cytokines, or mobilization of cytotoxic granules following recognition of tumor-antigens, yet there is no widely adopted standard method. Here we established an enhanced, yet simple, method for identifying simultaneously CD8
and CD4
tumor-specific reactive TILs
, using a combination of widely known and available flow cytometry assays. By combining the detection of intracellular CD137 and
production of TNF and IFNγ after recognition of naturally-presented tumor antigens, we demonstrate that a larger fraction of tumor-specific and reactive CD8
TILs can be detected
compared to commonly used assays. This assay revealed multiple polyfunctionality-based clusters of both CD4
and CD8
tumor-specific reactive TILs.
, the combined detection of
,
, and
identified most of the tumor-specific reactive TIL repertoire. In conclusion, we describe a straightforward method for efficient identification of the tumor-specific reactive TIL repertoire
, which can be rapidly adopted in most cancer immunology laboratories. |
doi_str_mv | 10.3389/fimmu.2021.705422 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_656d1c3e4153414e9f09ed73929cd351</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_656d1c3e4153414e9f09ed73929cd351</doaj_id><sourcerecordid>2587738210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-34b68edd5cc2d433833d1aa1097815ed6a989421155fe3cccde559aa239ddf523</originalsourceid><addsrcrecordid>eNpVkt1u0zAUxyMEYtPYA3CDcslFU2wfO4lvkKqOQqVqSKNcW459knlK4pCPTrwQL8B78Ey4azutlo5sn4_fObL_UfSekjlALj-VrmmmOSOMzjMiOGOvokuapjwBxvjrF-eL6HoYHkhYXAKAeBtdAM9IlhJyGf25052z8dpiO7rSGT0638a-jMd7jLdT4_vkR4dmH4rvUJvR7YJ_vQmXDvvRux7jndPx0jeFa9HGNziiOUGWNxSyWby9Xc1i3YY2q9t_f2fxyte1f3RtFSjGV6075S-m0de-8tNw7L0IU1XYDu-iN6WuB7w-7lfRz9WX7fJbsvn-db1cbBIjgI8J8CLN0VphDLM8PBOApVpTIrOcCrSplrnkjFIhSgRjjEUhpNYMpLWlYHAVrQ9c6_WD6nrX6P638tqpJ4fvK6X70ZkaVSpSSw0gp6E15ShLItFmIJk0FgQNrM2BNTxiNxVntHrqghXB1ICK5mCNSY0ymSkU10WuJFCmGAEtLSWZlmnAfT7gAqtBa8KH9bo-o55HWnevKr9TueBA6H6ej0dA739NOIyqcYPButYthhdXTORZBjmjJKTSQ6rp_TD0WD63oUTt1aee1Kf26lMH9YWaDy_ne644aQ3-AzR01_g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2587738210</pqid></control><display><type>article</type><title>Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens</title><source>PubMed (Medline)</source><creator>Draghi, Arianna ; Chamberlain, Christopher Aled ; Khan, Shawez ; Papp, Krisztian ; Lauss, Martin ; Soraggi, Samuele ; Radic, Haja Dominike ; Presti, Mario ; Harbst, Katja ; Gokuldass, Aishwarya ; Kverneland, Anders ; Nielsen, Morten ; Westergaard, Marie Christine Wulff ; Andersen, Mads Hald ; Csabai, Istvan ; Jönsson, Göran ; Szallasi, Zoltan ; Svane, Inge Marie ; Donia, Marco</creator><creatorcontrib>Draghi, Arianna ; Chamberlain, Christopher Aled ; Khan, Shawez ; Papp, Krisztian ; Lauss, Martin ; Soraggi, Samuele ; Radic, Haja Dominike ; Presti, Mario ; Harbst, Katja ; Gokuldass, Aishwarya ; Kverneland, Anders ; Nielsen, Morten ; Westergaard, Marie Christine Wulff ; Andersen, Mads Hald ; Csabai, Istvan ; Jönsson, Göran ; Szallasi, Zoltan ; Svane, Inge Marie ; Donia, Marco</creatorcontrib><description>Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current
assays identifying tumor-specific functional activation measure the upregulation of surface molecules,
production of antitumor cytokines, or mobilization of cytotoxic granules following recognition of tumor-antigens, yet there is no widely adopted standard method. Here we established an enhanced, yet simple, method for identifying simultaneously CD8
and CD4
tumor-specific reactive TILs
, using a combination of widely known and available flow cytometry assays. By combining the detection of intracellular CD137 and
production of TNF and IFNγ after recognition of naturally-presented tumor antigens, we demonstrate that a larger fraction of tumor-specific and reactive CD8
TILs can be detected
compared to commonly used assays. This assay revealed multiple polyfunctionality-based clusters of both CD4
and CD8
tumor-specific reactive TILs.
, the combined detection of
,
, and
identified most of the tumor-specific reactive TIL repertoire. In conclusion, we describe a straightforward method for efficient identification of the tumor-specific reactive TIL repertoire
, which can be rapidly adopted in most cancer immunology laboratories.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2021.705422</identifier><identifier>PMID: 34707600</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Antigens, CD - analysis ; Antigens, Neoplasm - immunology ; Apyrase - analysis ; Cancer and Oncology ; Cancer och onkologi ; CD137 (4-1BB) ; CD4-Positive T-Lymphocytes - chemistry ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - chemistry ; CD8-Positive T-Lymphocytes - immunology ; Clinical Medicine ; Datasets as Topic ; Flow Cytometry ; Humans ; immune-monitoring ; immune-responses to cancer ; Immunology ; Integrin alpha Chains - analysis ; Interferon-gamma - analysis ; Interferon-gamma - biosynthesis ; Interferon-gamma - genetics ; Klinisk medicin ; Lymphocyte Activation - genetics ; Lymphocytes, Tumor-Infiltrating - chemistry ; Lymphocytes, Tumor-Infiltrating - immunology ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Neoplasm Proteins - analysis ; Neoplasm Proteins - biosynthesis ; Neoplasm Proteins - genetics ; Single-Cell Analysis ; single-cell technologies ; Transcriptome ; Tumor Microenvironment - immunology ; Tumor Necrosis Factor Receptor Superfamily, Member 9 - analysis ; Tumor Necrosis Factor-alpha - analysis ; Tumor Necrosis Factor-alpha - biosynthesis ; Tumor Necrosis Factor-alpha - genetics ; tumor-infiltrating lymphocytes (TILs) ; tumor-specific activation ; tumor-specific reactivity</subject><ispartof>Frontiers in immunology, 2021-10, Vol.12, p.705422-705422</ispartof><rights>Copyright © 2021 Draghi, Chamberlain, Khan, Papp, Lauss, Soraggi, Radic, Presti, Harbst, Gokuldass, Kverneland, Nielsen, Westergaard, Andersen, Csabai, Jönsson, Szallasi, Svane and Donia.</rights><rights>Copyright © 2021 Draghi, Chamberlain, Khan, Papp, Lauss, Soraggi, Radic, Presti, Harbst, Gokuldass, Kverneland, Nielsen, Westergaard, Andersen, Csabai, Jönsson, Szallasi, Svane and Donia 2021 Draghi, Chamberlain, Khan, Papp, Lauss, Soraggi, Radic, Presti, Harbst, Gokuldass, Kverneland, Nielsen, Westergaard, Andersen, Csabai, Jönsson, Szallasi, Svane and Donia</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-34b68edd5cc2d433833d1aa1097815ed6a989421155fe3cccde559aa239ddf523</citedby><cites>FETCH-LOGICAL-c534t-34b68edd5cc2d433833d1aa1097815ed6a989421155fe3cccde559aa239ddf523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543011/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543011/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34707600$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/183dcc6c-c7cb-4ab8-9312-203a9d107a96$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Draghi, Arianna</creatorcontrib><creatorcontrib>Chamberlain, Christopher Aled</creatorcontrib><creatorcontrib>Khan, Shawez</creatorcontrib><creatorcontrib>Papp, Krisztian</creatorcontrib><creatorcontrib>Lauss, Martin</creatorcontrib><creatorcontrib>Soraggi, Samuele</creatorcontrib><creatorcontrib>Radic, Haja Dominike</creatorcontrib><creatorcontrib>Presti, Mario</creatorcontrib><creatorcontrib>Harbst, Katja</creatorcontrib><creatorcontrib>Gokuldass, Aishwarya</creatorcontrib><creatorcontrib>Kverneland, Anders</creatorcontrib><creatorcontrib>Nielsen, Morten</creatorcontrib><creatorcontrib>Westergaard, Marie Christine Wulff</creatorcontrib><creatorcontrib>Andersen, Mads Hald</creatorcontrib><creatorcontrib>Csabai, Istvan</creatorcontrib><creatorcontrib>Jönsson, Göran</creatorcontrib><creatorcontrib>Szallasi, Zoltan</creatorcontrib><creatorcontrib>Svane, Inge Marie</creatorcontrib><creatorcontrib>Donia, Marco</creatorcontrib><title>Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current
assays identifying tumor-specific functional activation measure the upregulation of surface molecules,
production of antitumor cytokines, or mobilization of cytotoxic granules following recognition of tumor-antigens, yet there is no widely adopted standard method. Here we established an enhanced, yet simple, method for identifying simultaneously CD8
and CD4
tumor-specific reactive TILs
, using a combination of widely known and available flow cytometry assays. By combining the detection of intracellular CD137 and
production of TNF and IFNγ after recognition of naturally-presented tumor antigens, we demonstrate that a larger fraction of tumor-specific and reactive CD8
TILs can be detected
compared to commonly used assays. This assay revealed multiple polyfunctionality-based clusters of both CD4
and CD8
tumor-specific reactive TILs.
, the combined detection of
,
, and
identified most of the tumor-specific reactive TIL repertoire. In conclusion, we describe a straightforward method for efficient identification of the tumor-specific reactive TIL repertoire
, which can be rapidly adopted in most cancer immunology laboratories.</description><subject>Antigens, CD - analysis</subject><subject>Antigens, Neoplasm - immunology</subject><subject>Apyrase - analysis</subject><subject>Cancer and Oncology</subject><subject>Cancer och onkologi</subject><subject>CD137 (4-1BB)</subject><subject>CD4-Positive T-Lymphocytes - chemistry</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - chemistry</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Clinical Medicine</subject><subject>Datasets as Topic</subject><subject>Flow Cytometry</subject><subject>Humans</subject><subject>immune-monitoring</subject><subject>immune-responses to cancer</subject><subject>Immunology</subject><subject>Integrin alpha Chains - analysis</subject><subject>Interferon-gamma - analysis</subject><subject>Interferon-gamma - biosynthesis</subject><subject>Interferon-gamma - genetics</subject><subject>Klinisk medicin</subject><subject>Lymphocyte Activation - genetics</subject><subject>Lymphocytes, Tumor-Infiltrating - chemistry</subject><subject>Lymphocytes, Tumor-Infiltrating - immunology</subject><subject>Medical and Health Sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Neoplasm Proteins - analysis</subject><subject>Neoplasm Proteins - biosynthesis</subject><subject>Neoplasm Proteins - genetics</subject><subject>Single-Cell Analysis</subject><subject>single-cell technologies</subject><subject>Transcriptome</subject><subject>Tumor Microenvironment - immunology</subject><subject>Tumor Necrosis Factor Receptor Superfamily, Member 9 - analysis</subject><subject>Tumor Necrosis Factor-alpha - analysis</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><subject>tumor-infiltrating lymphocytes (TILs)</subject><subject>tumor-specific activation</subject><subject>tumor-specific reactivity</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkt1u0zAUxyMEYtPYA3CDcslFU2wfO4lvkKqOQqVqSKNcW459knlK4pCPTrwQL8B78Ey4azutlo5sn4_fObL_UfSekjlALj-VrmmmOSOMzjMiOGOvokuapjwBxvjrF-eL6HoYHkhYXAKAeBtdAM9IlhJyGf25052z8dpiO7rSGT0638a-jMd7jLdT4_vkR4dmH4rvUJvR7YJ_vQmXDvvRux7jndPx0jeFa9HGNziiOUGWNxSyWby9Xc1i3YY2q9t_f2fxyte1f3RtFSjGV6075S-m0de-8tNw7L0IU1XYDu-iN6WuB7w-7lfRz9WX7fJbsvn-db1cbBIjgI8J8CLN0VphDLM8PBOApVpTIrOcCrSplrnkjFIhSgRjjEUhpNYMpLWlYHAVrQ9c6_WD6nrX6P638tqpJ4fvK6X70ZkaVSpSSw0gp6E15ShLItFmIJk0FgQNrM2BNTxiNxVntHrqghXB1ICK5mCNSY0ymSkU10WuJFCmGAEtLSWZlmnAfT7gAqtBa8KH9bo-o55HWnevKr9TueBA6H6ej0dA739NOIyqcYPButYthhdXTORZBjmjJKTSQ6rp_TD0WD63oUTt1aee1Kf26lMH9YWaDy_ne644aQ3-AzR01_g</recordid><startdate>20211011</startdate><enddate>20211011</enddate><creator>Draghi, Arianna</creator><creator>Chamberlain, Christopher Aled</creator><creator>Khan, Shawez</creator><creator>Papp, Krisztian</creator><creator>Lauss, Martin</creator><creator>Soraggi, Samuele</creator><creator>Radic, Haja Dominike</creator><creator>Presti, Mario</creator><creator>Harbst, Katja</creator><creator>Gokuldass, Aishwarya</creator><creator>Kverneland, Anders</creator><creator>Nielsen, Morten</creator><creator>Westergaard, Marie Christine Wulff</creator><creator>Andersen, Mads Hald</creator><creator>Csabai, Istvan</creator><creator>Jönsson, Göran</creator><creator>Szallasi, Zoltan</creator><creator>Svane, Inge Marie</creator><creator>Donia, Marco</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AGCHP</scope><scope>AOWAS</scope><scope>D8T</scope><scope>D95</scope><scope>ZZAVC</scope><scope>DOA</scope></search><sort><creationdate>20211011</creationdate><title>Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens</title><author>Draghi, Arianna ; Chamberlain, Christopher Aled ; Khan, Shawez ; Papp, Krisztian ; Lauss, Martin ; Soraggi, Samuele ; Radic, Haja Dominike ; Presti, Mario ; Harbst, Katja ; Gokuldass, Aishwarya ; Kverneland, Anders ; Nielsen, Morten ; Westergaard, Marie Christine Wulff ; Andersen, Mads Hald ; Csabai, Istvan ; Jönsson, Göran ; Szallasi, Zoltan ; Svane, Inge Marie ; Donia, Marco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-34b68edd5cc2d433833d1aa1097815ed6a989421155fe3cccde559aa239ddf523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antigens, CD - analysis</topic><topic>Antigens, Neoplasm - immunology</topic><topic>Apyrase - analysis</topic><topic>Cancer and Oncology</topic><topic>Cancer och onkologi</topic><topic>CD137 (4-1BB)</topic><topic>CD4-Positive T-Lymphocytes - chemistry</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - chemistry</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Clinical Medicine</topic><topic>Datasets as Topic</topic><topic>Flow Cytometry</topic><topic>Humans</topic><topic>immune-monitoring</topic><topic>immune-responses to cancer</topic><topic>Immunology</topic><topic>Integrin alpha Chains - analysis</topic><topic>Interferon-gamma - analysis</topic><topic>Interferon-gamma - biosynthesis</topic><topic>Interferon-gamma - genetics</topic><topic>Klinisk medicin</topic><topic>Lymphocyte Activation - genetics</topic><topic>Lymphocytes, Tumor-Infiltrating - chemistry</topic><topic>Lymphocytes, Tumor-Infiltrating - immunology</topic><topic>Medical and Health Sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Neoplasm Proteins - analysis</topic><topic>Neoplasm Proteins - biosynthesis</topic><topic>Neoplasm Proteins - genetics</topic><topic>Single-Cell Analysis</topic><topic>single-cell technologies</topic><topic>Transcriptome</topic><topic>Tumor Microenvironment - immunology</topic><topic>Tumor Necrosis Factor Receptor Superfamily, Member 9 - analysis</topic><topic>Tumor Necrosis Factor-alpha - analysis</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><topic>tumor-infiltrating lymphocytes (TILs)</topic><topic>tumor-specific activation</topic><topic>tumor-specific reactivity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Draghi, Arianna</creatorcontrib><creatorcontrib>Chamberlain, Christopher Aled</creatorcontrib><creatorcontrib>Khan, Shawez</creatorcontrib><creatorcontrib>Papp, Krisztian</creatorcontrib><creatorcontrib>Lauss, Martin</creatorcontrib><creatorcontrib>Soraggi, Samuele</creatorcontrib><creatorcontrib>Radic, Haja Dominike</creatorcontrib><creatorcontrib>Presti, Mario</creatorcontrib><creatorcontrib>Harbst, Katja</creatorcontrib><creatorcontrib>Gokuldass, Aishwarya</creatorcontrib><creatorcontrib>Kverneland, Anders</creatorcontrib><creatorcontrib>Nielsen, Morten</creatorcontrib><creatorcontrib>Westergaard, Marie Christine Wulff</creatorcontrib><creatorcontrib>Andersen, Mads Hald</creatorcontrib><creatorcontrib>Csabai, Istvan</creatorcontrib><creatorcontrib>Jönsson, Göran</creatorcontrib><creatorcontrib>Szallasi, Zoltan</creatorcontrib><creatorcontrib>Svane, Inge Marie</creatorcontrib><creatorcontrib>Donia, Marco</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SWEPUB Lunds universitet full text</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Lunds universitet</collection><collection>SwePub Articles full text</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Draghi, Arianna</au><au>Chamberlain, Christopher Aled</au><au>Khan, Shawez</au><au>Papp, Krisztian</au><au>Lauss, Martin</au><au>Soraggi, Samuele</au><au>Radic, Haja Dominike</au><au>Presti, Mario</au><au>Harbst, Katja</au><au>Gokuldass, Aishwarya</au><au>Kverneland, Anders</au><au>Nielsen, Morten</au><au>Westergaard, Marie Christine Wulff</au><au>Andersen, Mads Hald</au><au>Csabai, Istvan</au><au>Jönsson, Göran</au><au>Szallasi, Zoltan</au><au>Svane, Inge Marie</au><au>Donia, Marco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2021-10-11</date><risdate>2021</risdate><volume>12</volume><spage>705422</spage><epage>705422</epage><pages>705422-705422</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current
assays identifying tumor-specific functional activation measure the upregulation of surface molecules,
production of antitumor cytokines, or mobilization of cytotoxic granules following recognition of tumor-antigens, yet there is no widely adopted standard method. Here we established an enhanced, yet simple, method for identifying simultaneously CD8
and CD4
tumor-specific reactive TILs
, using a combination of widely known and available flow cytometry assays. By combining the detection of intracellular CD137 and
production of TNF and IFNγ after recognition of naturally-presented tumor antigens, we demonstrate that a larger fraction of tumor-specific and reactive CD8
TILs can be detected
compared to commonly used assays. This assay revealed multiple polyfunctionality-based clusters of both CD4
and CD8
tumor-specific reactive TILs.
, the combined detection of
,
, and
identified most of the tumor-specific reactive TIL repertoire. In conclusion, we describe a straightforward method for efficient identification of the tumor-specific reactive TIL repertoire
, which can be rapidly adopted in most cancer immunology laboratories.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>34707600</pmid><doi>10.3389/fimmu.2021.705422</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-3224 |
ispartof | Frontiers in immunology, 2021-10, Vol.12, p.705422-705422 |
issn | 1664-3224 1664-3224 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_656d1c3e4153414e9f09ed73929cd351 |
source | PubMed (Medline) |
subjects | Antigens, CD - analysis Antigens, Neoplasm - immunology Apyrase - analysis Cancer and Oncology Cancer och onkologi CD137 (4-1BB) CD4-Positive T-Lymphocytes - chemistry CD4-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - chemistry CD8-Positive T-Lymphocytes - immunology Clinical Medicine Datasets as Topic Flow Cytometry Humans immune-monitoring immune-responses to cancer Immunology Integrin alpha Chains - analysis Interferon-gamma - analysis Interferon-gamma - biosynthesis Interferon-gamma - genetics Klinisk medicin Lymphocyte Activation - genetics Lymphocytes, Tumor-Infiltrating - chemistry Lymphocytes, Tumor-Infiltrating - immunology Medical and Health Sciences Medicin och hälsovetenskap Neoplasm Proteins - analysis Neoplasm Proteins - biosynthesis Neoplasm Proteins - genetics Single-Cell Analysis single-cell technologies Transcriptome Tumor Microenvironment - immunology Tumor Necrosis Factor Receptor Superfamily, Member 9 - analysis Tumor Necrosis Factor-alpha - analysis Tumor Necrosis Factor-alpha - biosynthesis Tumor Necrosis Factor-alpha - genetics tumor-infiltrating lymphocytes (TILs) tumor-specific activation tumor-specific reactivity |
title | Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A12%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rapid%20Identification%20of%20the%20Tumor-Specific%20Reactive%20TIL%20Repertoire%20via%20Combined%20Detection%20of%20CD137,%20TNF,%20and%20IFN%CE%B3,%20Following%20Recognition%20of%20Autologous%20Tumor-Antigens&rft.jtitle=Frontiers%20in%20immunology&rft.au=Draghi,%20Arianna&rft.date=2021-10-11&rft.volume=12&rft.spage=705422&rft.epage=705422&rft.pages=705422-705422&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2021.705422&rft_dat=%3Cproquest_doaj_%3E2587738210%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c534t-34b68edd5cc2d433833d1aa1097815ed6a989421155fe3cccde559aa239ddf523%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2587738210&rft_id=info:pmid/34707600&rfr_iscdi=true |